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We are grateful for the opportunity to respond to the points raised by Alizadeh and colleagues. First, 
we addressed between-cohort heterogeneity (clustering) by stratifying all Cox models on cohort. 
This allows the baseline mortality hazard to vary between cohorts, while assuming a common effect 
of covariates across cohorts(1). We have found previously that effects of important prognostic 
factors such as CD4 count are consistent across cohorts. Webtable 1 of our paper shows that 
calendar time effects were consistent across subgroups defined by values of important prognostic 
factors. 
For the analyses of prognosis from 1 year after starting ART, we presented analyses (see Figure 2) in 
which we controlled for CD4 count and viral load measured at both start of ART and at one year 
after starting ART. These measurements were all made before start of follow up in those analyses. 
We do not agree that it would have been appropriate to address the effects of these time-
dependent variables through joint modelling of time-to-event and longitudinal outcomes: our 
analysis appropriately addressed the extent to which controlling for one-year measurements 
attenuated associations with their baseline values. 
We agree that we cannot exclude selection bias due to informative censoring. As noted by Alizadeh 
and colleagues, we reported that some patient characteristics predicted loss to follow up. However, 
this finding does not imply that censoring was informative, since our analyses conditioned on the 
variables that predicted loss to follow up. Informative censoring is unlikely to have substantially 
biased our results because cohorts have good recording of deaths and linkage to death registries. 
Sensitivity analyses such as those proposed by Kaciroti et al(2) would be of interest but were outside 
the scope of our paper. 
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